New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide
Go back to New Exploratory Analysis Showed Romosozumab Increased Estimated Bone Strength More Than Teriparatide| Amgen Inc (NASDAQ: AMGN) | Delayed: 385.65 +5.87 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $379.78 | 52 Week High | $176.85 | |||
| Open | $378.51 | 52 Week Low | $133.64 | |||
| Day High | $386.50 | P/E | 58.08 | |||
| Day Low | $378.51 | EPS | $6.64 | |||
| Volume | 8,528,108 | |||||
| (NYSE: UCB) | Delayed: 34.69 +0.05 (0.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $34.64 | 52 Week High | $ | |||
| Open | $34.58 | 52 Week Low | $ | |||
| Day High | $34.75 | P/E | N/A | |||
| Day Low | $34.32 | EPS | $ | |||
| Volume | 1,715,545 | |||||
| UCB Unsponsored ADR (AMEX: UCBJY) | Delayed: 119.58 -0.16 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.74 | 52 Week High | $46.25 | |||
| Open | $120.12 | 52 Week Low | $32.74 | |||
| Day High | $120.92 | P/E | N/A | |||
| Day Low | $119.12 | EPS | $0.00 | |||
| Volume | 41,735 | |||||
